| Dr Peter Wrigley, MD | |
|
611 W Park St, Urbana, IL 61801-2529 | |
| (217) 383-3440 | |
| Not Available |
| Full Name | Dr Peter Wrigley |
|---|---|
| Gender | Male |
| Speciality | Neurology |
| Experience | 14 Years |
| Location | 611 W Park St, Urbana, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144660572 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 036150593 (Illinois) | Primary |
| 2084N0400X | Psychiatry & Neurology - Neurology | 270964 (Massachusetts) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| The Carle Foundation Hospital | Urbana, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Carle Health Care Incorporated | 3577515774 | 808 |
News Archive
"A physical active lifestyle opens the gateway to a preventive lifestyle including healthy diets" - this was the main message from a scientific presentation of Prof. Wolgang Schlicht, Institute of Sport and Health Sciences, Stuttgart University, held during the last meeting of the EU supported Food Cluster Initiative in Ghent, Belgium.
Celldex Therapeutics, Inc. today announced that patient screening has initiated in a Phase 2 trial of rindopepimut in combination with Avastin in patients with recurrent epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, called the "ReACT Study."
As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site reaction that can occur in some patients who have received the Moderna mRNA-1273 vaccine.
A landmark study led by UNC School of Medicine researchers has identified the first genetic locus for anorexia nervosa and has revealed that there may also be metabolic underpinnings to this potentially deadly illness.
CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.
› Verified 4 days ago
| Entity Name | Carle Health Care Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154653947 PECOS PAC ID: 3577515774 Enrollment ID: O20100513000829 |
News Archive
"A physical active lifestyle opens the gateway to a preventive lifestyle including healthy diets" - this was the main message from a scientific presentation of Prof. Wolgang Schlicht, Institute of Sport and Health Sciences, Stuttgart University, held during the last meeting of the EU supported Food Cluster Initiative in Ghent, Belgium.
Celldex Therapeutics, Inc. today announced that patient screening has initiated in a Phase 2 trial of rindopepimut in combination with Avastin in patients with recurrent epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, called the "ReACT Study."
As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site reaction that can occur in some patients who have received the Moderna mRNA-1273 vaccine.
A landmark study led by UNC School of Medicine researchers has identified the first genetic locus for anorexia nervosa and has revealed that there may also be metabolic underpinnings to this potentially deadly illness.
CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.
› Verified 4 days ago
| Entity Name | Carle West Physician Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467074138 PECOS PAC ID: 8921420308 Enrollment ID: O20200613000147 |
News Archive
"A physical active lifestyle opens the gateway to a preventive lifestyle including healthy diets" - this was the main message from a scientific presentation of Prof. Wolgang Schlicht, Institute of Sport and Health Sciences, Stuttgart University, held during the last meeting of the EU supported Food Cluster Initiative in Ghent, Belgium.
Celldex Therapeutics, Inc. today announced that patient screening has initiated in a Phase 2 trial of rindopepimut in combination with Avastin in patients with recurrent epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, called the "ReACT Study."
As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site reaction that can occur in some patients who have received the Moderna mRNA-1273 vaccine.
A landmark study led by UNC School of Medicine researchers has identified the first genetic locus for anorexia nervosa and has revealed that there may also be metabolic underpinnings to this potentially deadly illness.
CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Peter Wrigley, MD 611 W. Park St., Fapc, Urbana, IL 61801 Ph: (217) 902-5291 | Dr Peter Wrigley, MD 611 W Park St, Urbana, IL 61801-2529 Ph: (217) 383-3440 |
News Archive
"A physical active lifestyle opens the gateway to a preventive lifestyle including healthy diets" - this was the main message from a scientific presentation of Prof. Wolgang Schlicht, Institute of Sport and Health Sciences, Stuttgart University, held during the last meeting of the EU supported Food Cluster Initiative in Ghent, Belgium.
Celldex Therapeutics, Inc. today announced that patient screening has initiated in a Phase 2 trial of rindopepimut in combination with Avastin in patients with recurrent epidermal growth factor variant III (EGFRvIII)-positive glioblastoma, called the "ReACT Study."
As the speed and scale of vaccinations against the SARS-CoV-2 virus ramps up globally, researchers at Massachusetts General Hospital (MGH) are calling for greater awareness and communication around a delayed injection-site reaction that can occur in some patients who have received the Moderna mRNA-1273 vaccine.
A landmark study led by UNC School of Medicine researchers has identified the first genetic locus for anorexia nervosa and has revealed that there may also be metabolic underpinnings to this potentially deadly illness.
CytRx Corporation, a biopharmaceutical company and a leader in molecular chaperone regulation technology, today announced that a paper published in the peer-reviewed journal Gerontology concluded that molecular chaperone amplification may represent a "significant strategy" in the future design of anti-aging pharmaceuticals.
› Verified 4 days ago
Harry L Bremer, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 602 W. University Avenue, Neurology, Urbana, IL 61801 Phone: 217-383-3440 Fax: 217-383-3171 | |
Dr. Marshall Louis Garrick, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1109 S Lincoln Ave, 3 Rd Floor, Urbana, IL 61801 Phone: 217-333-2705 Fax: 217-244-1758 | |
Dr. Daniel Carlos Chavez, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3311 | |
Chriss Ilunga Mulumba, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3311 | |
Dhanya Baskaran, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-474-6271 | |
Mr. Nakib Ahmed Mansuri, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3311 | |
Bara Abdul Karim Saadah, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 611 W Park St, Urbana, IL 61801 Phone: 217-383-3311 |